Immunotherapeutic Potential of Oncolytic H-1 Parvovirus: Hints of Glioblastoma Microenvironment Conversion towards Immunogenicity. [electronic resource]
Producer: 20180716ISSN:- 1999-4915
- Clinical Trials, Phase I as Topic
- Clinical Trials, Phase II as Topic
- Glioblastoma -- therapy
- H-1 parvovirus -- growth & development
- Humans
- Immunologic Factors
- Microglia -- immunology
- Oncolytic Virotherapy -- methods
- Oncolytic Viruses -- growth & development
- T-Lymphocytes, Cytotoxic -- immunology
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.